Do you have treatment experience with Padcev?

CSNSupportTeam

Title for post: Do you have treatment experience with Padcev?

First and Last Name: Michelle Colero

Email: info@bladdercancercanada.org

Phone: 1-866-674-8889

Website: https://bladdercancercanada.org/en/

The Canadian government will soon be reviewing the use of Padcev (enfortumab vedotin) in combination with Keytruda (pembrolizumab) to locally advancer or metastatic urothelial cancer. Bladder Cancer Canada will be making a submission to ensure that patient voices are represented and considered during the review process.

Does this survey apply to you?

We are looking for patients with locally advancer or metastatic urothelial cancer and patients who have been treated with Padcev in combination with Keytruda to talk about their experience.

Please note that caregivers may answer questions on behalf of the patient where the patient is unable or unavailable.

YOU DO NOT NEED TO LIVE IN CANADA TO PARTICIPATE.

If you are interested in talking about your experiences, we would like to ask you to complete this survey: https://www.surveymonkey.com/r/padcev2

*Research studies require IRB review and certification. See here for guidelines.

**Contact information above will be publicly posted with the recruitment post content.